Cell-function engineering via large-scale genome construction (Geno-Writing Platform)
| Date | Round | Amount |
|---|---|---|
| Jul 2025 | Funding round Japanese cell-engineering startup Logomix raised JPY 2.8bn (Angel Bridge, JAFCO, UTokyo IPC, Globis Capital Partners, Itochu Technology Ventures, Delight Ventures and others) to accelerate US expansion. | $18M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.